VKTX
Viking Therapeutics, Inc.
Stock
$29.94−0.57 (−1.87%)Close Oct 2, 2026
- Shareholders' equity, 2025
- $639M
- YoY, 2025
- −27.4%
- 5-year CAGR
- +21.2%
- 10-year CAGR
- +53.6%
Shareholders' equity
Shareholders' equity by fiscal year
| Period | Equity | YoY |
|---|---|---|
| 2025 | $639M | −27.4% |
| 2024 | $880M | +152.6% |
| 2023 | $348M | +139.8% |
| 2022 | $145M | −28.0% |
| 2021 | $202M | −17.4% |
| 2020 | $244M | −11.8% |
| 2019 | $277M | −6.9% |
| 2018 | $298M | +2,111.5% |
| 2017 | $13M | +67.4% |
| 2016 | $8.0M | −7.8% |
| 2015 | $8.7M | — |
| 2014 | −$22M | — |